IL6 and osteonecrosis: In the piglet model of ischemic ONFH, IL-6 inhibitors inhibit osteoclastogenesis and delay progression of osteonecrosis (Ren et al., 2021), further highlighting the important role of IL-6 in the chronic inflammation of osteonecrosis.